Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about VC Recap: Strong Funding For Biotech, Fintech; KKR Enters Venture Capital
Venture Capital

VC Recap: Strong Funding For Biotech, Fintech; KKR Enters Venture Capital

by trusted insight posted 2years ago 584 views
Introducing Trusted Insight's Venture Capital Recap, a compilation of the most important venture capital news from the previous day. Here are the stories you may have missed:

B2B Fintech Strong Amid Market Crunch. Venture capital has hit a plateau, according to some analysts. “After $100M+ checks flowed freely to VC-backed companies through much of 2015, the mega-round trend has settled into a lower range through 2016,” concluded KPMG and CB Insights in their Q3 2016 venture capital report. Read more

November VC: The Rockefellers, Chinese Funds Pour Cash Into Biotech. “China" and “biotech” are buzzwords that have consistently appeared throughout Trusted Insight’s monthly venture capital deals roundups. It should come as no surprise that in November, these themes made headlines once again. Read more

KKR Raises A $711M Tech Growth Fund. KKR, the global investment firm, is announcing a $711 million close this morning on its KKR Next Generation Technology Growth Fund, which it plans to use to back growth-stage companies in the technology, media and telco industries in North America, Europe and Israel. Read more

India's Funding Freeze Is Thawing. Investors had turned cautious in 2016, after the euphoria in 2015, when they raced to invest in Indian start-ups, which drove valuations. Read more